This August, members of ASBMT’s leadership, including ASBMT President Dr. John DiPersio and President-Elect Dr. Navneet Majhail, had the chance to meet with Seema Verma, Administrator for the Centers of Medicare and Medicaid (CMS) to discuss Medicare inpatient final rule for CAR-T therapies.
Administrator Verma asked ASBMT to submit comments regarding potential short-term and long-term solutions within the current pay systems, along with potential options for demonstration projects. ASBMT and our partners at the American Society of Hematology (ASH) worked together to identify possible solutions for the primary areas of concern.
On Thursday, Nov. 1, ASBMT and ASH submitted a joint letter to CMS, outlining what we believe is the best course of action in this matter. The organizations will continue to work together on this important issue on behalf of our respective membership communities.
Click here to read the letter in full.